Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Interest Expenses: 2009-2024

Historic Interest Expenses for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $42.9 million.

  • UNITED THERAPEUTICS's Interest Expenses fell 70.30% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.3 million, marking a year-over-year decrease of 51.50%. This contributed to the annual value of $42.9 million for FY2024, which is 27.66% down from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Interest Expenses is $42.9 million, which was down 27.66% from $59.3 million recorded in FY2023.
  • UNITED THERAPEUTICS's Interest Expenses' 5-year high stood at $59.3 million during FY2023, with a 5-year trough of $18.6 million in FY2021.
  • In the last 3 years, UNITED THERAPEUTICS's Interest Expenses had a median value of $42.9 million in 2024 and averaged $44.9 million.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Interest Expenses plummeted by 46.83% in 2020 and then surged by 83.02% in 2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Interest Expenses (Yearly) stood at $23.5 million in 2020, then declined by 20.85% to $18.6 million in 2021, then surged by 74.19% to $32.4 million in 2022, then skyrocketed by 83.02% to $59.3 million in 2023, then fell by 27.66% to $42.9 million in 2024.